As of 2025-10-25, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -4.23 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.24 USD, the upside of Aldeyra Therapeutics Inc is -180.63%.
Based on its market price of 5.24 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 180.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.23 - -4.23 | -4.23 | -180.63% |
| P/E | (1.72) - (2.59) | (2.15) | -141.1% |
| DDM - Stable | (6.36) - (20.54) | (13.45) | -356.7% |
| DDM - Multi | (6.29) - (16.22) | (9.11) | -273.9% |
| Market Cap (mil) | 313.88 |
| Beta | 3.19 |
| Outstanding shares (mil) | 59.90 |
| Enterprise Value (mil) | 313.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.50% |
| Cost of Debt | 5.00% |
| WACC | 10.20% |